World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
33705
World Ranking
9670
National Ranking
295

Overview

Myriam Labopin is affiliated with Université Paris Cité in France and has an extensive research portfolio in the field of medicine, with a significant focus on hematology. Their work encompasses a broad range of topics closely related to hematopoietic stem cell transplantation and leukemia research.

The main fields of study covered in Myriam Labopin's research include:

  • Medicine

Within this broader medical field, they have contributed significantly to several subfields:

  • Hematology
  • Public Health, Environmental and Occupational Health
  • Oncology
  • Immunology
  • Genetics

The primary topics of Myriam Labopin's research activity emphasize stem cell transplantation and leukemia, including:

  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Polyomavirus and Related Diseases
  • Neutropenia and Cancer Infections
  • Immune Cell Function and Interaction

Key recent papers authored by or associated with Myriam Labopin exemplify their research interests and include:

  • Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients, 2020, Bone Marrow Transplantation
  • COVID-19 outcomes in patients with hematologic disease, 2020, Bone Marrow Transplantation
  • Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP), 2020, Frontiers in Immunology
  • Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation, 2020, Haematologica
  • Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation, 2021, JACC CardioOncology

Frequent co-authors in Myriam Labopin's network include:

  • Mohamad Mohty
  • Arnon Nagler
  • Fabio Ciceri
  • Didier Blaise
  • Éolia Brissot

The scientist has published extensively in specific venues known for hematology and transplantation research. These venues include:

  • Bone Marrow Transplantation
  • Blood
  • Transplantation and Cellular Therapy
  • American Journal of Hematology
  • Biology of Blood and Marrow Transplantation

Best Publications

  • Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia

    Vanderson Rocha;Myriam Labopin;Guillermo Sanz;William Arcese

  • Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

    Christoph Schmid;Myriam Labopin;Arnon Nagler;Martin Bornhäuser

  • Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT).

    M. Aoudjhane;M. Labopin;N. C. Gorin;A. Shimoni

  • A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions.

    Aurelien Latouche;Aurelien Latouche;Arthur Allignol;Jan Beyersmann;Myriam Labopin

  • Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases

    Dominique Farge;Myriam Labopin;Alan Tyndall;Athanasios Fassas

  • Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation

    Eliane Gluckman;Barbara Cappelli;Francoise Bernaudin;Myriam Labopin

  • A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation

    Fabio Ciceri;Myriam Labopin;Franco Aversa;Jakob M. Rowe

  • Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation.

    J A Snowden;R Saccardi;M Allez;S Ardizzone

  • Impact of FLT3 Internal Tandem Duplication on the Outcome of Related and Unrelated Hematopoietic Transplantation for Adult Acute Myeloid Leukemia in First Remission: A Retrospective Analysis

    Salut Brunet;Myriam Labopin;Jordi Esteve;Jan Cornelissen

  • Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019

    Rafael F. Duarte;Myriam Labopin;Peter Bader;Grzegorz W. Basak

  • Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders

    Christine Bellanné-Chantelot;Isabelle Chaumarel;Myriam Labopin;Florence Bellanger

  • Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP–EBMT analysis on patients with AML in remission

    A Ruggeri;M Labopin;F Ciceri;M Mohty

  • Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study

    Francesco Frassoni;Francesca Gualandi;Marina Podestà;Anna Maria Raiola

  • Reduced Intensity Conditioning Compared With Myeloablative Conditioning Using Unrelated Donor Transplants in Patients With Acute Myeloid Leukemia

    Olle Ringdén;Myriam Labopin;Gerhard Ehninger;Dietger Niederwieser

  • Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation.

    Mohamad Mohty;Myriam Labopin;Liisa Volin;Alois Gratwohl

  • Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

    Nimitha R Mathew;Nimitha R Mathew;Francis Baumgartner;Lukas Braun;David O'Sullivan

  • Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation

    Christoph Schmid;Myriam Labopin;Arnon Nagler;Dietger Niederwieser

  • CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT

    Martin Schmidt-Hieber;Myriam Labopin;Dietrich Beelen;Liisa Volin

  • Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome

    V. Runde;T.J.M. de Witte;R. Arnold;A. Gratwohl

  • Treatment With Granulocyte Colony-Stimulating Factor After Allogeneic Bone Marrow Transplantation for Acute Leukemia Increases the Risk of Graft-Versus-Host Disease and Death: A Study From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

    Olle Ringdén;Myriam Labopin;Norbert Claude Gorin;Katarina Le Blanc

Frequent Co-Authors

Arnon Nagler
Arnon Nagler Sheba Medical Center
Gérard Socié
Gérard Socié Université Paris Cité
Jan J. Cornelissen
Jan J. Cornelissen Erasmus University Rotterdam
Fabio Ciceri
Fabio Ciceri Vita-Salute San Raffaele University
Bipin N. Savani
Bipin N. Savani Vanderbilt University Medical Center
Vanderson Rocha
Vanderson Rocha Universidade de São Paulo
Ibrahim Yakoub-Agha
Ibrahim Yakoub-Agha University of Lille
Christoph Schmid
Christoph Schmid University of Augsburg
Jürgen Finke
Jürgen Finke University of Freiburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens up diverse educational options beyond traditional medical school. For registered nurses aiming to advance quickly, adn to np programs online offer a streamlined path from an associate degree in nursing to becoming a nurse practitioner. These flexible programs make it easier for working professionals to upskill without interrupting their careers.

Interested in nutrition and preventative health? Pursuing an online bachelor's in nutrition can be a strategic move, leading to roles in public health, wellness coaching, or clinical dietetics. Likewise, for those seeking leadership in healthcare, top online mha programs that are cahme accredited equip graduates with vital management skills tailored for hospital and health services administration.

Many programs also accommodate non-traditional students. For example, nurses can expand their credentials conveniently with an rn to bsn with no clinicals program, reducing time spent away from work. Exploring these online options can accelerate your pathway into more specialized or advanced healthcare roles.

Best Scientists Citing Myriam Labopin

Trending Scientists

Recently Published Articles